This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

European Parliament looks set to ditch AI liability, patents bills after EPP move

By Luca Bertuzzi and Inbar Preiss ( June 12, 2025, 10:18 GMT | Insight) -- The European Parliament looks increasingly likely to not oppose the withdrawal of legislative proposals on AI liability and standard essential patents after the largest political group, the center-right European People’s Party, said it would not challenge the European Commission's plan to ditch the proposed laws. The commission suggested dropping the draft laws in February due to insufficient political support, though a final decision isn't due until later this summer.The European Parliament looks increasingly likely to not oppose the withdrawal of legislative proposals on AI liability and standard essential patents after the largest political group, the center-right European People’s Party, or EPP, said it would not challenge the European Commission's plans to ditch the proposed laws. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login